Jamie H. Von Roenn, MD; Robert L. Murphy, MD; Kathleen M. Weber, RN, BSN; Lisa M. Williams, RN, BSN; Sigmund A. Weitzman, MD
Cachexia is a common problem in patients infected with human immunodeficiency virus (HIV) and predicts a poor prognosis (1, 2). The deleterious effects of malnutrition on immunity to infection are well recognized (3, 4). Therefore, evaluation of nutritional status and treatment, if indicated, in persons with HIV infection may be particularly important.
Recently, megestrol acetate, a synthetic orally active progesterone widely used for the therapy of advanced breast cancer, was reported to stimulate the appetite and produce weight gain (5). On the basis of this information, we initiated megestrol acetate therapy in persons with HIV infection and severe anorexia and
Learn more about subscription options.
Register Now for a free account.
Von Roenn JH, Murphy RL, Weber KM, Williams LM, Weitzman SA. Megestrol Acetate for Treatment of Cachexia Associated with Human Immunodeficiency Virus (HIV) Infection. Ann Intern Med. 1988;109:840–841. doi: 10.7326/0003-4819-109-10-840
Download citation file:
Published: Ann Intern Med. 1988;109(10):840-841.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only